Atria Selective Prolongation by NIP-142, an Antiarrhythmic Agent, of Refractory Period and Action Potential Duration in Guinea Pig Myocardium
-
- Matsuda Tomoyuki
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences Biological Research Laboratories, Nissan Chemical Industries, Ltd.
-
- Takeda Kentaro
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Ito Mie
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Yamagishi Reiko
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Tamura Miku
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Nakamura Hideki
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Tsuruoka Noriko
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Saito Tomoaki
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Masumiya Haruko
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Suzuki Takeshi
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences School of Material Science, Japan Advanced Institute of Science and Technology
-
- Iida-Tanaka Naoko
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences Department of Food Science, Otsuma Woman's University
-
- Itokawa-Matsuda Maho
- Biological Research Laboratories, Nissan Chemical Industries, Ltd.
-
- Yamashita Toru
- Biological Research Laboratories, Nissan Chemical Industries, Ltd.
-
- Tsuruzoe Nobutomo
- Biological Research Laboratories, Nissan Chemical Industries, Ltd.
-
- Tanaka Hikaru
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
-
- Shigenobu Koki
- Department of Pharmacology, Toho University School of Pharmaceutical Sciences
この論文をさがす
説明
NIP-142 is a novel benzopyran compound that was shown to prolong the atrial effective refractory period and terminate experimental atrial fibrillation in the dog. In the present study, we examined the effects of NIP-142 on isolated guinea pig myocardium and on the G-protein-coupled inwardly rectifying potassium channel current (acetylcholine-activated potassium current; IKACh) expressed in Xenopus oocytes. NIP-142 (10 and 100 μM) concentration-dependently prolonged the refractory period and action potential duration in the atrium but not in the ventricle. E-4031 and 4-aminopyridine prolonged action potential duration in both left atrium and right ventricle. Prolongation by NIP-142 of the atrial action potential duration was observed at stimulation frequencies between 0.5 and 5 Hz. In contrast, the prolongation by E-4031 was not observed at higher frequencies. Tertiapin, a blocker of IKACh, prolonged action potential duration in the atrium but not in the ventricle. NIP-142 completely reversed the carbachol-induced shortening of atrial action potential duration. NIP-142 (1 to 100 μM), as well as tertiapin (0.1 to 100 nM), concentration-dependently blocked IKACh expressed in Xenopus oocytes; the blockade by NIP-142 was not affected by membrane voltage. In conclusion, NIP-142 was shown to prolong atrial refractory period and action potential duration through blockade of IKACh which may possiblly explain its previously described antiarrhythic activity. NIP-142 has pharmacological properties that are different from classical class III antiarrhythmic agents such as atria specificity and lack of reverse frequency dependence, and thus appears promising for the treatment of supraventricular arrhythmia.<br>
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 98 (1), 33-40, 2005
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680152689792
-
- NII論文ID
- 10025727826
-
- NII書誌ID
- AA11806667
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 7313617
-
- PubMed
- 15879679
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可